Global Sanger Sequencing Services Market Overview

The Global Sanger Sequencing Services market size is estimated to reach $1,218 million by 2026, growing at a CAGR of 16.1% over the forecast period of 2021-2026. Sanger sequencing can be delineated as a chain closing process and a "Deoxyribonucleic acid (DNA) Sequencing" built on dye deoxynucleotides in DNA polymerizing reaction where nucleotides are a blend of three components phosphate, nitrogenous base, and sugar. Frequently the process is used to draw precise order of nucleotides.

Even though the technique was discovered in the late 1970s, it still finds its applications in modern-day activities. Recently, the sanger sequence is being used extensively to sequence protein spikes present in SARS-CoV-2. The Sanger sequencing services market outlook is captivating as research and development activities are ramping up due to the innumerable flow of riches. Moreover, augmenting mergers and acquisitions of prominent players in the respective market are factors set to drive the growth of the Sanger Sequencing Services Market for the period.

Impact of COVID-19:

COVID-19 had a positive impact on the market. Rising research & developmental activities during COVID-19, the increase in numbers have outperformed more than ever of their previous selves as revenue of pharmaceutical and biopharmaceutical firms proliferated ascribing to the COVID-19 crisis. Thus there was positive growth in the market.

Key Takeaways from Global Sanger Sequencing Services Market Report:

·   Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level – for Application, Product Type, End-user, and by different industry verticals.

·   Understand the different dynamics influencing the market – key driving factors, challenges, and hidden opportunities.

·   Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

·   Analyze the sales and distribution channels across key geographies to improve top-line revenues.

·   Understand the industry supply chain with a deep dive on the value augmentation at each step to optimize value and bring efficiencies in your processes.

·   Get a quick outlook on the market entropy – M&As, deals, partnerships, product launches of all key players for the past four years.

·   Evaluate the supply-demand gaps, import-export statistics, and regulatory landscape for more than the top 20 countries globally for the market.

By Application, the market for the cancer segment to grow at the highest CAGR during the forecast period

During the forecast period, the market for the cancer segment is predicted to develop at the fastest rate of XX%. This growth is due to rising cancer cases in almost every continent ascribing to poor ingestion habits of people, hampered immunity due to lack of proper physical activity, and mounting use of cigarettes and alcohol to relieve stress. The cancer segment held the largest share in 2020. The growth is owing to the rising Application of cancer prevention by unearthing biomarkers. Such sequencing techniques brief doctors and researchers about occurred changes in genetic information. Moreover, the method is proficient in recording the most petite mutation and replications. 

End-user Pharmaceutical and Biopharmaceutical Segment will grow at the highest CAGR during the forecast period.

The pharmaceutical and biopharmaceutical segment is predicted to develop at the fastest CAGR during the projection period. This growth is due to rising mergers and acquisitions among companies to accomplish their research quests. Besides, extension in genome mapping and increased flow of hard cash in genomic research. The pharmaceutical and Biopharmaceutical segment organization held the largest share in 2020. The growth is due to the widespread use of sequencing techniques because they provide crucial information to researchers regarding possible mutations in genes and connotations with maladies. Moreover, they are of great help in detecting probable medicine targets and new drugs development.

North America to account for the largest market share during the forecast period.

North America held the largest share of the Sanger Sequencing Services market in 2020, with a global market share of 37.1%. The growth in this segment is owing to the factors such as the widespread presence of leading players in the pharmaceutical and biopharmaceutical sector. As of now, there are more than 6600 biopharmaceutical companies operational in the US. Furthermore, world-renowned academic and research institutes like Harvard, MIT, CIT, Stanford, and many more provide the continent with an edge in research activities.

The Asia Pacific is set to be the fastest-growing over 2021-2026. This growth is owing to shooting up life-threatening maladies like cancers as the faction of geriatric population is mounting with time. Additionally, prospering GDPs of nations like India and China are ensuing innumerable flows of riches into research and development activities.

Market Dynamics

Driver:  Rising cancer complications with the mounting elderly population are Anticipated to Boost Product Demand.

With shooting up the old age population around the globe, the threat of chronic illnesses has strengthened because, with old age, the immune system starts to perish. According to a survey, around 18-19% of the population in China falls under the elderly category as it is aging above 60. Similarly, the number whirl around 9-10% for India, the 2nd most populous nation. Therefore, the overall prevalence of chronic illnesses has augmented. 1 in 68 males in India has lung cancer whereas, for women, the number is 1 in 29. Where women are more afflicted with breast cancer compilations.

Additionally, the prevalence of cancer is also accruing in the North American nations. The US will have witnessed over 1.9 million cases of cancer in 2021. All these factors mentioned above are anticipated to surge the demand for the market.

Challenge: Extortionate price and lack of skilled professionals are Anticipated to Hamper Market Growth.

The few factors that are likely to strangle the growth of the respective market are the exorbitant price of Sanger sequencing and the lack of skilled professionals. Sanger sequencing is too excessive as compared to other sequencing techniques like NGS. It can cost more than $500 per 1000 bases. In comparison, NGS cost runs around only $0.50. furthermore, ascribing to lack of interest in the younger generation regarding scientific fields, a lesser number of skilled professionals can impact the growth market aversively.

Key Market Players

Key Players in the Global Sanger Sequencing Services Market consist of GenScript, Source BioScience, Nucleics, CeMIA SA, Genewiz, GenHunter Corporation, QuintaraBio, SciGenom Labs, LGC Limited, and Fasteris SA.

Recent Developments:

On September 26, 2018, Massachusetts-based life sciences company Brooks Automation (also known as Azenta) acquired Genewic Group, a famous genomic services provider firm headquartered in New Jersey. The total price paid by Azenta stands around $450 million to complete the acquisition process. It was the significant acquisition ever done by Azenta in the life sciences business.

Report Coverage and Scope

The report "Global Sanger Sequencing Services Market" by Research Informatic covers an in-depth detailed analysis for the following segment covered under the scope.

By Application

·         Procreative health

·         Personalized drug

·         Forensic

·         Diagnostics

·         Cancer

By Product Type

·         Classic

·         Modern

By End-user

·         Hospitals

·         Clinics

·         Pharmaceutical and Biopharmaceutical organization

·         Research and development institutions

By Geography

·         North America

·         Europe

·         APAC

·         RoW

Chapter 1 Sanger Sequencing Services Market Overview

1.1 Product Overview and Scope of Sanger Sequencing Services

1.2 Sanger Sequencing Services Market Segmentation By Application

1.2.1 Procreative health

1.2.2 Personalized drug

1.2.3 Forensic

1.2.4 Diagnostics

1.2.5 Cancer

1.3 Sanger Sequencing Services Market Segmentation By End User

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 Pharmaceutical and Biopharmaceutical organization

1.3.4 Research and development institutions

1.4 Sanger Sequencing Services Market Segmentation by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

1.5 Global Market Size (Value) of Sanger Sequencing Services (2015-2027)

Chapter 2 Global Economic Impact on Sanger Sequencing Services Industry

2.1 Global Macroeconomic Environment Analysis

2.1.1 Global Macroeconomic Analysis

2.1.2 Global Macroeconomic Environment Development Trend

2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Sanger Sequencing Services Market Competition by Manufacturers

3.1 Global Sanger Sequencing Services Production and Share by Manufacturers (2021 and 2021)

3.2 Global Sanger Sequencing Services Revenue and Share by Manufacturers (2021 and 2021)

3.3 Global Sanger Sequencing Services Average Price by Manufacturers (2021 and 2021)

3.4 Manufacturers Sanger Sequencing Services Manufacturing Base Distribution, Production Area and Product Type

3.5 Sanger Sequencing Services Market Competitive Situation and Trends

3.5.1 Sanger Sequencing Services Market Concentration Rate

3.5.2 Sanger Sequencing Services Market Share of Top 3 and Top 5 Manufacturers

3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Sanger Sequencing Services Production, Revenue (Value) by Region (2015-2021)

4.1 Global Sanger Sequencing Services Production by Region (2015-2021)

4.2 Global Sanger Sequencing Services Production Market Share by Region (2015-2021)

4.3 Global Sanger Sequencing Services Revenue (Value) and Market Share by Region (2015-2021)

4.4 Global Sanger Sequencing Services Production, Revenue, Price and Gross Margin (2015-2021)

4.5 North America Sanger Sequencing Services Production, Revenue, Price and Gross Margin (2015-2021)

4.6 Europe Sanger Sequencing Services Production, Revenue, Price and Gross Margin (2015-2021)

4.7 China Sanger Sequencing Services Production, Revenue, Price and Gross Margin (2015-2021)

4.8 Japan Sanger Sequencing Services Production, Revenue, Price and Gross Margin (2015-2021)

4.9 Southeast Asia Sanger Sequencing Services Production, Revenue, Price and Gross Margin (2015-2021)

4.10 India Sanger Sequencing Services Production, Revenue, Price and Gross Margin (2015-2021)

Chapter 5 Global Sanger Sequencing Services Supply (Production), Consumption, Export, Import by Regions (2015-2021)

5.1 Global Sanger Sequencing Services Consumption by Regions (2015-2021)

5.2 North America Sanger Sequencing Services Production, Consumption, Export, Import by Regions (2015-2021)

5.3 Europe Sanger Sequencing Services Production, Consumption, Export, Import by Regions (2015-2021)

5.4 China Sanger Sequencing Services Production, Consumption, Export, Import by Regions (2015-2021)

5.5 Japan Sanger Sequencing Services Production, Consumption, Export, Import by Regions (2015-2021)

5.6 Southeast Asia Sanger Sequencing Services Production, Consumption, Export, Import by Regions (2015-2021)

5.7 India Sanger Sequencing Services Production, Consumption, Export, Import by Regions (2015-2021)

Chapter 6 Global Sanger Sequencing Services Production, Revenue (Value), Price Trend by Type

6.1 Global Sanger Sequencing Services Production and Market Share by Type (2015-2021)

6.2 Global Sanger Sequencing Services Revenue and Market Share by Type (2015-2021)

6.3 Global Sanger Sequencing Services Price by Type (2015-2021)

6.4 Global Sanger Sequencing Services Production Growth by Type (2015-2021)

Chapter 7 Global Sanger Sequencing Services Market Analysis by Application

7.1 Global Sanger Sequencing Services Consumption and Market Share by Application (2015-2021)

7.2 Global Sanger Sequencing Services Consumption Growth Rate by Application (2015-2021)

7.3 Market Drivers and Opportunities

7.3.1 Potential Applications

7.3.2 Emerging Markets/Countries

Chapter 8 Sanger Sequencing Services Manufacturing Cost Analysis

8.1 Sanger Sequencing Services Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labour Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Sanger Sequencing Services

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Sanger Sequencing Services Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Sanger Sequencing Services Major Manufacturers in 2021

9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

Chapter 12 Global Sanger Sequencing Services Market Forecast (2021-2027)

12.1 Global Sanger Sequencing Services Production, Revenue Forecast (2021-2027)

12.2 Global Sanger Sequencing Services Production, Consumption Forecast by Regions (2021-2027)

12.3 Global Sanger Sequencing Services Production Forecast by Type (2021-2027)

12.4 Global Sanger Sequencing Services Consumption Forecast by Application (2021-2027)

12.5 Sanger Sequencing Services Price Forecast (2021-2027)

Chapter 13 Appendix